About
Small Molecules, Therapeutic Antibody
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule Pharmaceutical
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
10
As Collaborator
1
Total Enrollment
1,878
By Phase
PHASE1: 2PHASE4: 1PHASE2: 2PHASE3: 2
By Status
COMPLETED: 6TERMINATED: 3RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05495204Collaborator
External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA
N/ACompleted
141 participants
Started: Aug 5, 2022 · Completed: Feb 20, 2023
NCT05383456Lead Sponsor
The Visceral Adiposity Measurement and Observation Study
N/ACompleted
196 participants
Started: Apr 18, 2022 · Completed: Oct 30, 2023
NCT05388474Lead Sponsor
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab
N/ARecruiting
200 participants
Started: Mar 22, 2022 · Completed: Jun 30, 2026
NCT04706962Lead Sponsor
TH1902 in Patients With Advanced Solid Tumors
PHASE1Active, not recruiting
70 participants
Started: Mar 4, 2021 · Completed: Jan 31, 2026
NCT01579695Lead Sponsor
Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®
N/ATerminated
391 participants
Started: Feb 28, 2013 · Completed: Aug 31, 2018
Locations (1)
Headquarters
Montréal, QC, Canada
Map
Loading map...